SYRE

NASDAQ · Equity

Spyre Therapeutics Inc.

US Healthcare Biotechnology

Latest week
29 May 2026
Close
73.500000
Fair value
25.983542
Expectation
Positive 56.17%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
73.50
12-Week Change
84.26%
Trend Signal
Active
Expectation
Positive 56.17%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
88.10
Market Dynamics
1.28

Over the latest 12 completed weeks ending 2026-05-29, SYRE rose 84.26%, moving from 39.89 to 73.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 88.10 and has improved across the 12-week window. Market Dynamics is 1.28 on the latest week. Expectation is positive at 56.17%.